| Titolo |
Pubblicato in |
Anno |
| Protection against severe COVID-19 after second booster dose of adapted bivalent (original/Omicron BA.4-5) mRNA vaccine in persons ≥ 60 years, by time since infection, Italy, 12 September to 11 December 2022 |
EUROSURVEILLANCE |
2023 |
| SARS-CoV-2 Breakthrough Infections According to the Immune Response Elicited after mRNA Third Dose Vaccination in COVID-19-Naïve Hospital Personnel |
BIOMEDICINES |
2023 |
| Early Warning Systems for Emerging Profiles of Antimicrobial Resistance in Italy: A National Survey |
INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH |
2023 |
| The Impact of Rotavirus Vaccination on Discharges for Pediatric Gastroenteritis in Italy: An Eleven Year (2009–2019) Nationwide Analysis |
VACCINES |
2023 |
| Relative effectiveness of monovalent and bivalent mRNA boosters in preventing severe COVID-19 due to omicron BA.5 infection up to 4 months post-administration in people aged 60 years or older in Italy: a retrospective matched cohort study |
THE LANCET INFECTIOUS DISEASES |
2023 |
| Relative effectiveness of bivalent Original/Omicron BA.4-5 mRNA vaccine in preventing severe COVID-19 in persons 60 years and above during SARS-CoV-2 Omicron XBB.1.5 and other XBB sublineages circulation, Italy, April to June 2023 |
EUROSURVEILLANCE |
2023 |
| Relative effectiveness of a 2nd booster dose of COVID-19 mRNA vaccine up to four months post administration in individuals aged 80 years or more in Italy. A retrospective matched cohort study |
VACCINE |
2023 |
| Estimated effectiveness of a primary cycle of protein recombinant vaccine nvx-cov2373 against covid-19 |
JAMA NETWORK OPEN |
2023 |
| Unveiling the incidences and trends of the neglected zoonosis cystic echinococcosis in Europe: a systematic review from the MEmE project |
THE LANCET INFECTIOUS DISEASES |
2022 |
| Tracking the progressive spread of the SARS-CoV-2 Omicron variant in Italy, December 2021 to January 2022 |
EUROSURVEILLANCE |
2022 |
| Focolaio di COVID-19 in un campo estivo nella Regione Piemonte (2021): descrizione, lezioni apprese e raccomandazioni per futuri campi estivi |
BOLLETTINO EPIDEMIOLOGICO NAZIONALE |
2022 |
| Assessing COVID-19-Related Excess Mortality Using Multiple Approaches—Italy, 2020–2021 |
INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH |
2022 |
| Epidemiological characteristics of COVID-19 cases in Italy: an analysis from a sex/gender perspective |
THE ITALIAN JOURNAL OF GENDER-SPECIFIC MEDICINE |
2022 |
| Effectiveness of an mRNA vaccine booster dose against SARS-CoV-2 infection and severe COVID-19 in persons aged ≥60 years and other high-risk groups during predominant circulation of the delta variant in Italy, 19 July to 12 December 2021 |
EXPERT REVIEW OF VACCINES |
2022 |
| Winning during a pandemic: epidemiology of SARS-CoV-2 during EURO2020 in Italy |
EPIDEMIOLOGY AND INFECTION |
2022 |
| Differences in the incidence and clinical outcomes of SARS-CoV-2 infection between Italian and non-Italian nationals using routine data |
PUBLIC HEALTH |
2022 |
| Characteristics of COVID-19 cases in Italy from a sex/gender perspective |
ANNALI DELL'ISTITUTO SUPERIORE DI SANITÀ |
2022 |
| Impatto della vaccinazione e della pregressa
diagnosi sul rischio di infezione e di malattia
severa associata a SARS-CoV-2: un’analisi
dei casi diagnosticati nel mese di ottobre
2022 |
Impatto della vaccinazione e della pregressa diagnosi sul rischio di infezione e di malattia severa associata a SARS-CoV-2: un’analisi dei casi diagnosticati nel mese di ottobre 2022. Nota tecnica. |
2022 |
| Il sistema di sorveglianza basato su eventi in Italia dal 2009 al 2021: verso una intelligence di sanità pubblica |
BOLLETTINO EPIDEMIOLOGICO NAZIONALE |
2022 |
| Risk and protective factors for {SARS}-{CoV}-2 reinfections, surveillance data, Italy, August 2021 to March 2022 |
EUROSURVEILLANCE |
2022 |
